Published [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year]
NEW YORK, NY – August 25, 2026 ( NEWMEDIAWIRE ) – Kaplan Fox & Kilsheimer LLP announces that a class motion lawsuit has been filed in opposition to ARS Prescribed capsules Inc. (“ARS” or the “Company”) (NASDAQ: SPRY) on behalf of investors that purchased or otherwise bought ARS securities between March 9, 2026 and June 24, 2026 (the “Class Length”).
Even as it’s most likely you’ll presumably possibly presumably be an investor in ARS and like suffered losses, it’s most likely you’ll presumably possibly presumably CLICK HERE to contact us. That you can additionally contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.
DEADLINE REMINDER: Even as it’s most likely you’ll presumably possibly presumably be a member of the proposed Class, it’s most likely you’ll presumably possibly presumably move the court no later than October 5, 2026 to operate a lead plaintiff for the purported class. Even as you like losses we aid you to contact us to learn more about the lead plaintiff course of. You wish now not gape to change into a lead plaintiff so to allotment in any imaginable recovery.
The complaint alleges on June 24, 2026, after the market closed, ARS printed an announcement providing an update on payer fetch entry to for neffy, which stated, in pertinent segment, “[d]espite determined payer discussions ongoing till mid-June, in step with newest feedback, no fresh industrial formulary additions or protection choices like been issued for neffy within the July 1, 2026 cycle.” Following this info, the mark of ARS inventory fell $2.52 per allotment, or 23.9%, to shut at $8.02 per allotment on June 25, 2026.
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally acknowledged legislation firm centered on complex litigation, with offices in Original York, Oakland, Los Angeles, Chicago, and Original Jersey. Based in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and person protection actions in federal and disclose courts nationwide, convalescing more than $10 billion for purchasers and the classes it has represented.
Kaplan Fox is widely regarded as one in all the nation’s premier plaintiffs’ securities litigation companies and has bought recognition from Chambers and Companions, Benchmark Litigation, Large Lawyers, and Lawdragon. Serving as lead or co-lead counsel in a complete lot of landmark cases, the firm has secured likely the most indispensable largest recoveries within the history of securities litigation, in conjunction with a $2.425 billion recovery on behalf of Bank of The USA shareholders in In re Bank of The USA – the largest recovery ever received for claims below Portion 14(a) of the Securities Exchange Act – $800 million recovered for the Arkansas Instructor Retirement Machine and other pension funds in ATRS v. Allianz Global Patrons, and a $475 million settlement in In re Merrill Lynch.
For a long time, Kaplan Fox has represented public pension funds, institutional investors, companies, and members in high-stakes litigation. By its successful advocacy and precedent-environment victories, the firm has helped shape indispensable areas of securities and company legislation while advancing accountability and holding investor pursuits.
This press release may possibly presumably possibly presumably presumably be thought about Authorized knowledgeable Selling in some jurisdictions below the acceptable legislation and ethical guidelines. Past results carry out now not guarantee future outcomes.
Even as you like any questions about this Peep, your rights, or your pursuits, please contact:
CONTACT:
Pamela A. Mayer
800 Third Avenue, 38th Floor
Original York, Original York 10022
(646) 315-9003
Laurence D. King
1999 Harrison Avenue, Suite 1501
Oakland, California 94612
(415) 772-4704
Contacting or submitting info to Kaplan Fox & Kilsheimer LLP doesn’t create an authorized knowledgeable-client relationship, nor an responsibility on the segment of Kaplan Fox to aid you as a consumer.
https://www.kaplanfox.com/case/ars-prescribed capsules-inc-investor-alert-learn-more-now/
Glance the distinctive release on www.newmediawire.com
